Literature DB >> 26720805

Differential Association of Generalized and Abdominal Obesity With Diabetic Retinopathy in Asian Patients With Type 2 Diabetes.

Ryan Eyn Kidd Man1, Charumathi Sabanayagam2, Peggy Pei-Chia Chiang3, Ling-Jun Li2, Jonathan Edward Noonan4, Jie Jin Wang5, Tien Yin Wong6, Gemmy Chui-Ming Cheung7, Gavin Siew Wei Tan7, Ecosse L Lamoureux8.   

Abstract

IMPORTANCE: The association between obesity and diabetic retinopathy (DR) is equivocal, possibly owing to the strong interrelation between generalized and abdominal obesity leading to a mutually confounding effect. To our knowledge, no study in Asia has investigated the independent associations of these 2 parameters with DR to date.
OBJECTIVE: To investigate the associations of generalized (defined by body mass index [BMI], calculated as weight in kilograms divided by height in meters squared) and abdominal obesity (assessed by waist to hip ratio [WHR]) with DR in a clinical sample of Asian patients with type 2 diabetes mellitus. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional clinic-based study was conducted at the Singapore National Eye Centre, a tertiary eye care institution in Singapore, from December 2010 to September 2013. We recruited 498 patients with diabetes. After exclusion of participants with ungradable retinal images and type 1 diabetes, 420 patients (mean [SD] age, 57.8 [7.5] years; 32.1% women) were included in the analyses. EXPOSURES: Body mass index and WHR as waist/hip circumference (in centimeters). MAIN OUTCOMES AND MEASURES: The presence and severity of DR were graded from retinal images using the modified Airlie House Classification into none (n = 189), mild-moderate (Early Treatment Diabetic Retinopathy Study scale score, 20-41; n = 125), and severe DR (Early Treatment Diabetic Retinopathy Study scale score ≥53; n = 118). The associations of BMI and WHR with DR were assessed using multinomial logistic regression models adjusting for age, sex, traditional risk factors, and mutually for BMI and WHR.
RESULTS: Among the total of 420 patients, the median (interquartile range) for BMI and WHR were 25.7 (5.7) and 0.94 (0.08), respectively. In multivariable models, BMI was inversely associated with mild-moderate and severe DR (odds ratio [OR], 0.90 [95% CI, 0.84-0.97] and OR, 0.92 [95% CI, 0.85-0.99] per 1-unit increase, respectively), while WHR was positively associated with mild-moderate and severe DR (OR, 3.49 [95% CI, 1.50-8.10] and OR, 2.68 [95% CI, 1.28-5.62] per 0.1-unit increase, respectively) in women (P for interaction = .006). No sex-specific associations were found between BMI and DR (P for interaction >.10). CONCLUSIONS AND RELEVANCE: In Asian patients with type 2 diabetes, a higher BMI appeared to confer a protective effect on DR, while higher WHR was associated with the presence and severity of DR in women. Our results may inform future clinical trials to determine whether WHR is a more clinically relevant risk marker than BMI for individuals with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26720805     DOI: 10.1001/jamaophthalmol.2015.5103

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  35 in total

1.  Relationship between body fat and diabetic retinopathy in patients with type 2 diabetes: a nationwide survey in Korea.

Authors:  In Cheol Hwang; Jeong Hun Bae; Joon Mo Kim
Journal:  Eye (Lond)       Date:  2019-02-13       Impact factor: 3.775

2.  Association of Generalized and Abdominal Obesity with Diabetic Retinopathy in Chinese Type 2 Diabetic Patients.

Authors:  Jiaxian Chen; Yanan Wan; Jian Su; Zheng Zhu; Engchun Pan; Chong Shen; Jinbo Wen; Kai Wang; Hao Yu; Yu Qin; Lan Cui; Jinyi Zhou; Ming Wu
Journal:  Acta Diabetol       Date:  2021-10-28       Impact factor: 4.280

3.  Obesity and risk of age-related eye diseases: a systematic review of prospective population-based studies.

Authors:  Clarissa Ng Yin Ling; Su Chi Lim; Jost B Jonas; Charumathi Sabanayagam
Journal:  Int J Obes (Lond)       Date:  2021-05-07       Impact factor: 5.095

4.  Association of anthropometric parameters as a risk factor for development of diabetic retinopathy in patients with diabetes mellitus.

Authors:  Aditya Verma; Ashok Jha; Ahmed Roshdy Alagorie; Rishi Sharma
Journal:  Eye (Lond)       Date:  2022-01-20       Impact factor: 3.775

5.  A novel prescription pedometer-assisted walking intervention and weight management for Chinese occupational population.

Authors:  Yingxiang Yu; Yiran Lv; Bin Yao; Liguang Duan; Xiaoyuan Zhang; Lan Xie; Cuiqing Chang
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

6.  The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes.

Authors:  Jacqueline Chua; Ai-Ru Chia; Miao Li Chee; Ryan Eyn Kidd Man; Gavin Siew Wei Tan; Ecosse L Lamoureux; Tien Yin Wong; Mary Foong-Fong Chong; Leopold Schmetterer
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

7.  Prevalence and risk factors for diabetic retinopathy in China: a multi-hospital-based cross-sectional study.

Authors:  Guihua Zhang; Haoyu Chen; Weiqi Chen; Mingzhi Zhang
Journal:  Br J Ophthalmol       Date:  2017-08-30       Impact factor: 4.638

8.  Association between the number of natural teeth and diabetic retinopathy among type 2 diabetes mellitus: The Korea national health and nutrition examination survey.

Authors:  Su Jeong Song; Kyungdo Han; Seong-Su Lee; Jun-Beom Park
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

9.  Risk factors of diabetic retinopathy and sight-threatening diabetic retinopathy: a cross-sectional study of 13 473 patients with type 2 diabetes mellitus in mainland China.

Authors:  Yan Liu; Jiarui Yang; Liyuan Tao; Huibin Lv; Xiaodan Jiang; Mingzhou Zhang; Xuemin Li
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

10.  Association of obesity with diabetic retinopathy in US adults with diabetes in a national survey.

Authors:  Guang-Ran Yang; Dongmei Li; Zidian Xie
Journal:  Endocr Connect       Date:  2021-06-30       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.